Richard Levy
Directeur/Membre du Conseil chez MADRIGAL PHARMACEUTICALS, INC.
Fortune : 2 M $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Jesse Shefferman | M | 52 | 7 ans | |
| Paul Friedman | M | 81 | 8 ans | |
| David Block | M | 64 |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 17 ans |
| John Borgeson | M | 62 | 8 ans | |
| Herve Hoppenot | M | 64 | 10 ans | |
| Felix Baker | M | 55 | 9 ans | |
| Rebecca Taub | M | 71 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 12 ans |
| Victor Perlroth | M | 51 | 15 ans | |
| Fred Craves | M | 78 | 13 ans | |
| Mark Ragosa | M | 50 | 6 ans | |
| Jacqueline Zummo | M | 43 | 7 ans | |
| Eben Tessari | M | 42 | 9 ans | |
| James Daly | M | 63 | 9 ans | |
| William Sibold | M | - | 1 ans | |
| Sanj Patel | M | 54 | 9 ans | |
| Edward Chiang | M | - | 13 ans | |
| Michael Megna | M | 53 | 6 ans | |
| Luke Beshar | M | 65 | 6 ans | |
| Barry Flannelly | M | 66 | 10 ans | |
| Jane Huang | M | 51 | 3 ans | |
| Rachel Frank | F | - | - | |
| Gregory Sargen | M | 58 | 5 ans | |
| Madelyn Zeylikman | F | - | 4 ans | |
| Robert Profusek | M | 73 | 6 ans | |
| Tracey McCain | F | 56 | 6 ans | |
| Justine O'Malley | M | - | 4 ans | |
| Thomas Tray | M | 46 | 19 ans | |
| Tai Yin Yang | M | 70 | 5 ans | |
| Ken Bate | M | 73 | 8 ans | |
| Roger Garceau | M | 70 | 5 ans | |
| Cynthia Smith | F | 55 | 3 ans | |
| Barry Quart | M | 67 | 9 ans | |
| Charles Bancroft | M | 65 | 4 ans | |
| Hannah Fry | F | 34 | 4 ans | |
| Kim Popovits | F | 65 | 6 ans | |
| G. Cole | M | 68 | 4 ans | |
| Stephen Biggar | M | 53 | 9 ans | |
| Mary J. Grendell | F | - | - | |
| Bassil Dahiyat | M | 53 | 6 ans | |
| Julian Baker | M | 57 | 1 ans | |
| Michael Solomon | M | 54 | 6 ans | |
| Paul Clancy | M | 62 | 9 ans | |
| Thomas Malley | M | 55 | 8 ans | |
| Jean-Jacques Bienaimé | M | 70 | 9 ans | |
| Almas Qudrat | F | - | 6 ans | |
| Kyle Rusconi | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 3 ans |
| Carole Huntsman | F | - | - | |
| Pablo Velazquez-Martin | M | - | - | |
| Raymond Cheong | M | 42 | 1 ans | |
| Ross Moat | M | 43 | 5 ans | |
| Stephen Dodge | M | - | - | |
| Robert Waltermire | M | 60 | 3 ans | |
| Charles Polsky | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Mark Barrett | M | - | - | |
| Peter Langmuir | M | - | 9 ans | |
| Martina Struck | M | - | 6 ans | |
| Melissa Manno | F | - | 7 ans | |
| David Broser | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Tina Ventura | F | - | - | |
| Christopher Frates | M | - | 3 ans | |
| Catalina Loveman | F | - | 9 ans | |
| John Paolini | M | 59 | 8 ans | |
| Scott Strome | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Patrick Fabbio | M | 56 | 1 ans | |
| Mark Lerner | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 10 ans |
| Raymond Schinazi | M | 74 |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Ronald Filippo | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Roy Whitfield | M | 70 | 23 ans | |
| Richard de Schutter | M | 83 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 14 ans |
| Christopher Heberlig | M | 49 | 5 ans | |
| Thomas Beetham | M | 55 | 6 ans | |
| Marc R. Schneebaum | M | 69 | 7 ans | |
| Scott Braunstein | M | 60 | 2 ans | |
| Lloyd Mackenzie | M | 56 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 10 ans |
| Stephen Mahoney | M | 53 | 4 ans | |
| Laurent Chardonnet | M | 59 | - | |
| Paul Trower | M | 54 | 18 ans | |
| Krishna Vaddi | M | 58 | 13 ans | |
| Eric Siegel | M | 60 | - | |
| Shelley McCloskey | F | 64 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 ans |
| Kelvin Neu | M | 50 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 ans |
| Michael Charles A. Booth | M | 53 | 7 ans | |
| Bryant Lim | M | 53 | 4 ans | |
| Blaine Davis | M | 50 | 2 ans | |
| David Milligan | M | 83 | 7 ans | |
| Alex Howarth | M | 55 | 3 ans | |
| Scott W. Hurley | M | 65 | - | |
| Joseph Papa | M | 68 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Sean Nolan | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 4 ans |
| Barry Michael Ariko | M | 78 | 14 ans | |
| David Hastings | M | 62 | 11 ans | |
| Elias Bendekgey | M | 66 | 6 ans | |
| Michael D. Casey | M | 78 | 17 ans | |
| John F. Niblack | M | 85 | - | |
| Barbara Troupin | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 ans |
| Carsten Boess | M | 57 | 5 ans | |
| Patricia A. Schreck | F | 70 | 8 ans | |
| Wendy Dixon | M | 68 | 12 ans | |
| Ashley Garry | M | - | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 94 | 94,95% |
| Canada | 5 | 5,05% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Richard Levy
- Réseau Personnel